Click here to


Are you sure ?

Yes, do it No, cancel

Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # | show all

Keywords: Targeted Radiotherapy
SU-F-KDBRB1-2Tumor Targeting and Cancer Cell Penetrating Theranostic Gadolinium Nanoparticles for Image-Guided Nanoparticle-Enhanced Radiation Therapy
W Liu*, J Deacon , H Yan , B Sun , Y Liu , D Hegan , K Roberts , P Glazer , Z Chen , R Nath , Yale University and Yale-New Haven Hospital, New Haven, CT
WE-AB-DBRA-11Biodistribution and Pharmacokinetic Analysis of a Targeted Alpha Particle Therapy
Christopher J. Tichacek1,2,3*, Mikalai M. Budzevich4 , Narges K. Tafreshi3 , Thaddeus J. Wadas5 , Mark L. McLaughlin6,7 , David L. Morse2,4,8 , Eduardo G. Moros1,2,3 , (1) Dept. of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, (2) Dept. of Physics, University of South Florida, Tampa, FL, (3) Dept. of Cancer Physiology, Moffitt Cancer Center, Tampa, FL, (4) Small Animal Imaging Laboratory, Moffitt Cancer Center, Tampa, FL, (5) Dept. of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, NC, (6) Dept. of Pharmaceutical Sciences, West Virginia University, Health Sciences Center, Morgantown, WV, (7) Modulation Therapeutics Inc., Morgantown, WV, (8) Dept. of Oncologic Sciences, University of South Florida, Tampa, FL.
WE-C1000-GePD-F4-1Accuracy of Predicting Post-Therapy Exposure Rate and Clearance Effective Half-Life of 131I-Metaiodobenzylguanidine From Dosimetric Study Measurements
W Erwin*, R Wendt, UT MD Anderson Cancer Center, Houston, TX